IPP Bureau
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
By IPP Bureau - August 23, 2023
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
By IPP Bureau - August 23, 2023
Eris Lifesciences enters into term loan agreement with Citi Bank
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
By IPP Bureau - August 23, 2023
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
LEO Pharma to acquire Timber Pharmaceuticals
By IPP Bureau - August 22, 2023
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors
By IPP Bureau - August 22, 2023
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
By IPP Bureau - August 22, 2023
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
By IPP Bureau - August 22, 2023
Oteseconazole Capsules were found to be safe and more effective than fluconazole
EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
By IPP Bureau - August 21, 2023
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Venus Remedies launches its flagship R&D drug Elores in Oman
By IPP Bureau - August 21, 2023
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
By IPP Bureau - August 21, 2023
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Healthcare is not just a sector, but a mission: Dr. Mansukh Mandaviya
By IPP Bureau - August 21, 2023
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
G20 Health Minister’s Meeting concludes in Gandhinagar, Gujarat
By IPP Bureau - August 21, 2023
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India bags automation order for Reliance Life Sciences' biopharmaceutical facilities
By IPP Bureau - August 21, 2023
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Dr. Agarwal's Health Care raises US$80 mn from TPG and Temasek to expand network to 300 hospitals
By IPP Bureau - August 20, 2023
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Lupin receives approval from USFDA for Bromfenac Ophthalmic
By IPP Bureau - August 20, 2023
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
